Percutaneous Coronary Intervention
Percutaneous Coronary Intervention in Chronic Total Occlusion
... Percutaneous coronary intervention in chronic total occlusion is a rapidly evolving area, being considered the last frontier of interventional ...this intervention to patients, as another ...
8
Clinical-epidemiological aspects of patients submitted to Percutaneous Coronary Intervention in a university hospital
... and Coronary Angiog- raphy, an invasive diagnostic method that identifies the pres- ence, extent, and severity of coronary atherosclerotic ...through Percutaneous Coronary Intervention ...
8
Clinical Study Prognostic Value of VEGF in Patients Submitted to Percutaneous Coronary Intervention
... after percutaneous coronary intervention for predicting major adverse cardiac events (MACE) in coronary artery disease (CAD) ...after intervention ( 𝑃 < ...
7
Outcome of Diabetic and Non-Diabetic Patients Undergoing Successful Percutaneous Coronary Intervention of Chronic Total Occlusion
... 17. Marso SP, Giorgi LV, Johnson WL, Huber KC, Laster SB, Shelton CJ, et al. Diabetes mellitus is associated with a shift in the temporal risk profile of in-hospital death after percutaneous coronary ...
4
Acute Myocardial Infarction and Primary Percutaneous Coronary Intervention at Night Time
... on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on ...
7
Successful retrieval of an unexpanded coronary stent from the left main coronary artery during primary percutaneous coronary intervention
... percutaneous coronary intervention (PCI). At the local hospital, the patient was treated with Aspirin 300 mg, Clopidogrel 300 mg, Enoxapa- rin 70 mg sc and analgesic agents. The electro- cardiogram ...
4
Impact of coronary dominance on in-hospital outcomes after percutaneous coronary intervention in patients with acute coronary syndrome.
... the coronary risk factors, BMI, comorbidities (cerebrovascular disease, chronic obstructive pulmonary disease, presence of chronic kidney disease stage $3, hemodialysis, peripheral artery disease), or past history ...
6
Für Sie gelesen: Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
... Methoden und Ergebnisse Viele Studien berichten von vorteilhaf- ten Effekten von TMZ auf die klinische Prognose nach Patienten mit ischämi- schen Herzerkrankungen. Um aber zu evaluieren, ob diese Benefi ts auch bei ...
5
Percutaneous Coronary Intervention Utilization and Appropriateness across the United States.
... In this large, national registry, we evaluated the association between geographic variation in PCI rates and the appropriateness of these procedures using contemporary Appropriate Use Criteria. We observed differences ...
13
Resistência ao clopidogrel: prevalência e variáveis associadas.
... 18. Bliden KP, DiChiara J, Tantry US, Bassi AK, Chaganti SK, Gurbel PA. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary ...
7
Arq. Bras. Cardiol. vol.95 número5 es v95n5a24
... of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients: a one year results of the CARDia (coronary artery revascularization in diabetics) ...
2
Arq. Bras. Cardiol. vol.97 número3
... descending coronary artery and from the right ITA to the left marginal coronary ...new coronary arteriography showed occlusion of the right ...underwent percutaneous coronary ...
3
A Inibição da Via Final Comum da Agregação Plaquetária Reduz o Fenômeno de Não Reperfusão Durante a Intervenção Coronária Percutânea Primária? Tirofiban no Infarto Agudo do miocárdio e a não ReperfusÃo (TIARA).
... Lemos JA, et al.; American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions. ACCF/AHA Guideline for the management of ST - elevation myocardial infarction. J Am Coll Cardiol. ...
6
Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients
... Clopidogrel and aspirin are the most commonly used medications worldwide for dual antiplatelet therapy after percutaneous coronary intervention. However, clopidogrel hyporesponsiveness related to ...
7
Braz. J. Cardiovasc. Surg. vol.28 número1
... recommend percutaneous coronary intervention (PCI) of unprotected left main coronary artery (ULMCA) with stents as a Class IIa or IIb alternative to coronary artery bypass graft (CABG) ...
10
Rev. Bras. Cardiol. Invasiva vol.21 número3
... for percutaneous coronary intervention (PCI) is still not widely used in our ...unstable coronary artery disease (CAD) treated with the transradial approach were ...0.30), coronary ...
5
Arq. Bras. Cardiol. vol.97 número4 en v97n4a19
... Primary percutaneous coronary intervention (PCI) has become the favored reperfusion strategy in acute ST-segment elevation myocardial infarction. Lower post-PCI myocardial perfusion grade, no-reflow ...
10
Safety and Efficacy of Intracoronary Vasodilators in the Treatment of No-Reflow after Primary Percutaneous Intervention in Patients with Acute ST-Elevation Myocardial Infarction: A Literature Review
... primary Percutaneous Coronary Intervention (PCI) for reperfusion of an infarct-related artery in the setting of Acute Myocardial Infarction (AMI), which may be asymptomatic or clinically present with ...
6
Síndromes coronarianas agudas: tratamento e estratificação de risco.
... Key Words : acute coronary syndromes, Non-ST ele- vation acute coronary syndrome, myocardial infarction, percutaneous coronary intervention, reperfusion treat- ment, risk stratii cation[r] ...
8
Arq. Bras. Cardiol. vol.93 número6
... Percutaneous Coronary Intervention and Adjunct Diagnostic Methods in Interventionist Cardiology (II Edition – 2008), Guidelines of the Brazilian Society of Cardiology on Professional and ...
1